Acalabrutinib-Obinutuzumab Improves Survival Vs Chemoimmunotherapy in Treatment-Naive CLL in the 6-Year Follow-up of ELEVATE-TN.
Jeff P Sharman,Miklos Egyed,Wojciech Jurczak,Alan P Skarbnik,Krish Patel, Ian W Flinn,Manali Kamdar,Talha Munir,Renata Walewska,Marie Hughes, Laura Maria Fogliato,Yair Herishanu,Versha Banerji,George A Follows,Patricia A Walker, Paolo Ghia, Ann Mh Janssens, John C Byrd, Emmanuelle France Ferrant,Alessandra Ferrajoli,William G Wierda, Catherine Wangui Wachira, Batul T Suterwala, Paulo A Palhares de Miranda,Veerendra Munugalavadla,Chuan-Chuan Wun, Jennifer A Woyach Blood（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper